Literature DB >> 11446840

The optimal form of urinary drainage after acute retention of urine.

M I Patel1, W Watts, A Grant.   

Abstract

OBJECTIVE: To assess the outcome of different forms of urinary drainage, particularly for urinary tract infection (UTI), operative findings and patient preference, in patients treated for acute urinary retention (AUR). PATIENTS AND METHODS: A feasibility trial was conducted of men presenting with AUR; after a short period of indwelling catheterization (IDC) patients were taught how to use clean intermittent self-catheterization (CISC). Patients who failed this were re-catheterized and taught to manage a valve, or failing this a leg bag, and then discharged home. The patients were followed to assess the occurrence of spontaneous voiding, UTI, findings at prostatectomy and patient satisfaction.
RESULTS: The CISC group (34 men) had a higher rate of spontaneous voiding than the IDC group (16 men; 56% vs 25%). The incidence of UTI was 32% in the CISC and 75% in the IDC group. At TURP, 20% in the CISC group had a UTI, compared with 69% in the IDC group. Patients using CISC preferred it and had fewer complications than the IDC group. The CISC group had a similar ability to manage and similar acceptance of their method of drainage as the IDC group.
CONCLUSION: CISC is managed and accepted well by patients who can use the technique and results in fewer UTIs. It should be considered in patients who present with AUR, and it may delay surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11446840     DOI: 10.1046/j.1464-410x.2001.02253.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  10 in total

Review 1.  Systematic review and meta-analysis on management of acute urinary retention.

Authors:  P D Yoon; V Chalasani; H H Woo
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-21       Impact factor: 5.554

Review 2.  Urinary retention and uterine leiomyomas: a case series and systematic review of the literature.

Authors:  Clara Q Wu; Guylaine Lefebvre; Helena Frecker; Heinrich Husslein
Journal:  Int Urogynecol J       Date:  2015-03-10       Impact factor: 2.894

Review 3.  The management of female urinary retention.

Authors:  Sara Ramsey; Michael Palmer
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Etiology and management of urinary retention in women.

Authors:  Amit Mevcha; Marcus J Drake
Journal:  Indian J Urol       Date:  2010-04

5.  Critical urologic skills and procedures in the emergency department.

Authors:  Maria R Ramos-Fernandez; Roberto Medero-Colon; Lorraine Mendez-Carreno
Journal:  Emerg Med Clin North Am       Date:  2013-02       Impact factor: 2.264

Review 6.  Non-surgical management of recurrent urinary tract infections in women.

Authors:  Paul A Bergamin; Anthony J Kiosoglous
Journal:  Transl Androl Urol       Date:  2017-07

7.  Clean Intermittent Self-Catheterization as a Treatment Modality for Urinary Retention: Perceptions of Urologists.

Authors:  Laurens Weynants; François Hervé; Veerle Decalf; Candy Kumps; Ronny Pieters; Bart de Troyer; Karel Everaert
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

8.  Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management.

Authors:  K Muruganandham; Deepak Dubey; Rakesh Kapoor
Journal:  Indian J Urol       Date:  2007-10

9.  Diethylstilbestrol 1 mg in the Treatment of Acute Urinary Retention due to Prostatic Obstruction in the Elderly: A Preliminary Study.

Authors:  Leonardo Oliveira Reis; Gustavo Borges De Mendonça; Bruno D Carneiro; Edson Schneider; Eduardo Varella Gewehr; André Meirelles; Fernandes Denardi; Antonio Gugliotta
Journal:  Adv Urol       Date:  2014-01-19

10.  Reducing the burden of regular indwelling urinary catheter changes in the catheter clinics: the opinion of patients and relatives on the practice of self-catheterization.

Authors:  Ikenna I Nnabugwu; Emeka I Udeh; Oghenekaro A Enivwenae; Fred O Ugwumba; Oyiogu F Ozoemena
Journal:  Patient Prefer Adherence       Date:  2014-09-02       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.